Fig. 3From: A Design of Experiment (DoE) based approach for development and optimization of nanosuspensions of telmisartan, a BCS class II antihypertensive drugParticle size analysis and Zeta potential of stabilized formulation by acid-base neutralization method after 90 daysBack to article page